Nuria Paúl

Dr. Nuria Paúl

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 September 2022 in Neuropsychology Review
Verified
Journal Article
Closed access
PDF file
VDVillalobos Dolores
Villalobos Dolores
LTLucia Torres-Simón
Lucia Torres-Simón
JPJavier Pacios
Javier Pacios
NPNuria Paúl
Nuria Paúl
DRDavid Del Río
David Del Río

4 August 2021 in The Spanish Journal of Psychology
Verified
Journal Article
Closed access
PDF file
EGEduardo García-Laredo
Eduardo García-Laredo
MCMiguel Ángel Castellanos
Miguel Ángel Castellanos
EBEsperanza Badaya
Esperanza Badaya
NPNuria Paúl
Nuria Paúl
RYRaquel Yubero
Raquel Yubero
JCJosé Chacón
José Chacón
The objective of the present study was to evaluate whether declarative memory deficits are related to executive function deficits (EF), since they could be a consequence of a poor organization of the material to memorize. This interaction between both cognitive processes can be studied simultaneously in a single task such as the Test of Memory Strategies (TSM). 23 patients with paranoid schizophrenic disorder, 11 with bipolar disorder with psychotic symptoms, 13 with bipolar disorder without psychotic symptoms and 15 healthy subjects were evaluated with the TSM; with the memory test Texts A and B (subtest of the Barcelona neuropsychological assessment battery), which assesses short-term and immediate recall without the influence of EF; and with the Trail Making Test (TMT): Part A (sustained attention) and Part B (executive control). The patients groups and the control group showed an improvement in memory performance across each of the TSM conditions. However, this facilitating effect of the strategies differed among the groups (the patients with higher EF deficits showed less improvement). Regarding these results, we conclude that this cognitive process cannot be independent of EF. However, due to the pilot nature of this study, it would be recommended to replicate these findings in new studies.

26 November 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
BCBrenda Chino
Brenda Chino
LTLucía Torres-Simón
Lucía Torres-Simón
AŻAgnieszka Żelwetro
Agnieszka Żelwetro
IRInmaculada Concepción Rodríguez-Rojo
Inmaculada Concepción Rodríguez-Rojo
ACAnna Carnes-Vendrell
Anna Carnes-Vendrell
FMFernando Maestú
Fernando Maestú
Background: This study aimed to explore the association between a verbal learning task that evaluates the potential mutual dependency between memory and executive functions (i.e., the Test of Memory Strategies, TMS) and cerebrospinal fluid (CSF) Alzheimer’s Disease (AD) biomarkers. Methods: A sample of 47 mild cognitive impairment (MCI) participants from Poland and Spain were classified according to the Erlangen Score Diagnostic Algorithm (ESA) into CSF- (n = 16) and CSF+ (n = 31) groups. Correlation analyses between TMS word-list conditions and CSF biomarkers were conducted. Additionally, an analysis of covariance was performed to define the effect on ESA classification in the sample, using as a covariable the country of origin of the participants. Results: Significant associations between the TMS-3 condition and Aβ42, t-tau, and p-tau were observed for the whole sample. In addition, the CSF- participants obtained higher cognitive performance in TMS-3 compared to the CSF+ group. This outcome persisted if the groups were based on Aβ42 scores, but not t-tau or p-tau values. Conclusions: These findings could indicate that poor performance on verbal learning tests may be affected by executive dysfunctions. Therefore, future intervention plans focused on training executive functions would be of interest to improve the ability of MCI patients to encode and organize information.

27 February 2015 in Brain Informatics
Verified
Journal Article
Open access
PDF file
ZSZaigham Faraz Siddiqui
Zaigham Faraz Siddiqui
GKGeorg Krempl
Georg Krempl
MSMyra Spiliopoulou
Myra Spiliopoulou
JPJose M. Peña
Jose M. Peña
NPNuria Paúl
Nuria Paúl
FMFernando Maestu
Fernando Maestu
Predicting the evolution of individuals is a rather new mining task with applications in medicine. Medical researchers are interested in the progression of a disease and/or how do patients evolve or recover when they are subjected to some treatment. In this study, we investigate the problem of patients’ evolution on the basis of medical tests before and after treatment after brain trauma: we want to understand to what extend a patient can become similar to a healthy participant. We face two challenges. First, we have less information on healthy participants than on the patients. Second, the values of the medical tests for patients, even after treatment started, remain well-separated from those of healthy people; this is typical for neurodegenerative diseases, but also for further brain impairments. Our approach encompasses methods for modelling patient evolution and for predicting the health improvement of different patients’ subpopulations, i.e. prediction of label if they recovered or not. We test our approach on a cohort of patients treated after brain trauma and a corresponding cohort of controls.

16 June 2023 in Alzheimer's & Dementia
Verified
Journal Article
Open access
BCBrenda N Chino
Brenda N Chino
LTLucia Torres
Lucia Torres
AŻAgnieszka Żelwetro
Agnieszka Żelwetro
IRInmaculada Concepción Rodríguez Rojo
Inmaculada Concepción Rodríguez Rojo
ACAnna Carnes-Vendrell
Anna Carnes-Vendrell
FMFernando Maestú
Fernando Maestú
Background: Diagnostic research criteria for Alzheimer’s Disease (AD) recommend the cerebrospinal fluid (CSF) as a sensible and validated biomarker to improve the accuracy of the prognosis regarding progression to dementia for people with mild cognitive impairment (MCI). Also, it has been established that episodic memory failure is a proxy for AD, while executive functions impairment could be leading to other types of dementia. One of the tests designed to simultaneously evaluate these cognitive functions with high sensitivity and specificity to discriminate between neurocognitive disorders is the Test of Memory Strategies (TMS). The main goals of the present study were 1) to assess the correlations between TMS and CSF markers (i.e., Aβ42, t‐tau, and p‐tau) in a sample of MCI patients, and 2) to provide additional validation for TMS as a clinical tool for Alzheimer’s Disease (AD) early detection.Method: 135 participants were recruited from a multicenter international study in Poland and Spain, but only 47 were selected (Mean age: 68.58 ± 10.03). The sample was split according to the Erlangen Score Diagnostic Algorithm (ESA) into: CSF ‐ (n = 11) and CSF + (n = 36). Correlations analyses between the five TMS word‐list conditions and CSF biomarkers were conducted, and analysis of covariance (ANCOVA) was performed to define the effect on ESA classification in the sample, using the site of origin of the participants as covariable.Results: Significant associations between the TMS‐3 condition and Aβ42, t‐tau, and p‐tau were observed for the whole sample. Also, the CSF‐ obtained a higher cognitive performance in the TMS‐3 than the possible AD group (CSF+).Conclusions: Our results revealed that combining CSF biomarker measures and TMS scores could contribute to a better characterization and a more precise approach to AD. Furthermore, considering that the TMS‐3 condition is mostly associated with executive functions, future interventions should focus on this cognitive construct and how it could affect the patient’s ability to encode and organize the information in memory.